Abiopharma

New Form SCHEDULE 13G/A - PepGen Inc. Filed: 2025-05-15 AccNo: 0000902664-25-002426 Size: 11 KB

New Form SCHEDULE 13G - Opus Genetics, Inc. Filed: 2025-05-15 AccNo: 0001104659-25-049511 Size: 11 KB

New Form 8-K - Nuo Therapeutics, Inc. Filed: 2025-05-15 AccNo: 0001437749-25-017214 Size: 148 KB Item 1.01: Entry into a Material Definitive Agreement

New Form SCHEDULE 13G/A - InspireMD, Inc. Filed: 2025-05-15 AccNo: 0001104659-25-049506 Size: 11 KB

New Form SCHEDULE 13G/A - GH Research PLC Filed: 2025-05-15 AccNo: 0000921895-25-001548 Size: 23 KB

New Form 8-K - Emmaus Life Sciences, Inc. Filed: 2025-05-15 AccNo: 0001213900-25-044286 Size: 241 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form SCHEDULE 13G/A - Unity Biotechnology, Inc. Filed: 2025-05-15 AccNo: 0001172661-25-002391 Size: 10 KB

New Form 4 - INSMED Inc Filed: 2025-05-15 AccNo: 0001628280-25-025985 Size: 6 KB

New Form 8-K - OMEROS CORP Filed: 2025-05-15 AccNo: 0001437749-25-017211 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 2.02: Results of Operations and Financial Condition Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 3.02: …

New Form SCHEDULE 13G/A - Terns Pharmaceuticals, Inc. Filed: 2025-05-15 AccNo: 0001193805-25-000669 Size: 8 KB

New Form 8-K - Phio Pharmaceuticals Corp. Filed: 2025-05-15 AccNo: 0001683168-25-003715 Size: 253 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits

New Form SCHEDULE 13G - FATE THERAPEUTICS INC Filed: 2025-05-15 AccNo: 0001193805-25-000667 Size: 8 KB

New Form SCHEDULE 13G/A - SenesTech, Inc. Filed: 2025-05-15 AccNo: 0000929638-25-001917 Size: 11 KB

60 Degrees Pharmaceuticals Announces First Quarter 2025 Results

New Form SCHEDULE 13G/A - BRIGHT MINDS BIOSCIENCES INC. Filed: 2025-05-15 AccNo: 0000950170-25-072739 Size: 10 KB